ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,306.04
0.02%
Dow Jones
38,852.86
-0.55%
US Dollar vs MXN
16.76294
-0.20%
Brent Oil
84.63
0.36%
Bitcoin
67,678.90
-0.90%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Catalyst Biosciences Inc (CBIO)

  7. Catalyst Biosciences Inc (CBIO) Noticias

CBIO

Catalyst Biosciences (CBIO)

Catalyst Biosciences Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CBIO
FechaHoraFuenteTítuloSímboloCompañía
02/05/202417:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
01/05/202415:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202407:49Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202407:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CBIOCatalyst Biosciences Inc
29/04/202407:46Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CBIOCatalyst Biosciences Inc
19/04/202415:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:CBIOCatalyst Biosciences Inc
26/03/202416:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CBIOCatalyst Biosciences Inc
21/03/202419:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CBIOCatalyst Biosciences Inc
24/01/202416:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
19/01/202415:05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
29/11/202315:01Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:CBIOCatalyst Biosciences Inc
22/11/202318:06Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
13/11/202316:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CBIOCatalyst Biosciences Inc
30/10/202311:00GlobeNewswire Inc.Catalyst Biosciences Announces Completion of Business Combination With Beijing Continent Pharmaceuticals and Implementation of Name Change and Reverse Stock SplitNASDAQ:CBIOCatalyst Biosciences Inc
29/10/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CBIOCatalyst Biosciences Inc
27/10/202316:10Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:CBIOCatalyst Biosciences Inc
26/10/202316:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CBIOCatalyst Biosciences Inc
24/10/202315:08Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:CBIOCatalyst Biosciences Inc
24/07/202315:40Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CBIOCatalyst Biosciences Inc
20/07/202307:57Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CBIOCatalyst Biosciences Inc
12/07/202315:30Edgar (US Regulatory)Form PRER14A - Preliminary Proxy Soliciting materialsNASDAQ:CBIOCatalyst Biosciences Inc
26/06/202315:07Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBIOCatalyst Biosciences Inc
20/06/202316:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBIOCatalyst Biosciences Inc
30/03/202315:14Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBIOCatalyst Biosciences Inc
28/02/202310:45AllPennyStocks.comBiotech Soars On Asset Purchase AgreementNASDAQ:CBIOCatalyst Biosciences Inc
28/02/202307:00GlobeNewswire Inc.Catalyst Biosciences Provides Corporate UpdateNASDAQ:CBIOCatalyst Biosciences Inc
13/02/202313:56Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBIOCatalyst Biosciences Inc
05/01/202315:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBIOCatalyst Biosciences Inc
05/01/202305:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBIOCatalyst Biosciences Inc
27/12/202206:00GlobeNewswire Inc.Catalyst Biosciences Completes First Steps in Reverse Merger PlanNASDAQ:CBIOCatalyst Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CBIO

Su Consulta Reciente

TIDE
YFIUSDT
yearn.finance
COIN
DEXIUST
Dexioprotocol
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados